CALiD Publication List
Updated August 4, 2026

Publications
Yazdanfar M, Zepeda J, Dean R, Wu J, Levy C, Goldberg D, Lammert C, Prenner S, Reddy KR, Pratt D, Forman L, Assis DN, Lytvyak E, Montano-Loza AJ, Gordon SC, Carey EJ, Ahn J, Schlansky B, Korzenik J, Karagozian R, Hameed B, Chandna S, Yu L, Bowlus CL. African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis. Hepatol Commun. 2024 Jan 29;8(2):e0366. doi:10.1097/HC9.0000000000000366. PMID: 38285883; PMCID: PMC10830082.

​Dean R, Yazdanfar M, Zepeda J, Levy C, Lammert C, Pratt D, Gordon SC, Forman L, Assis DN, McGirr A, McLaughlin M, Mukherjee S, Gungabissoon U, Bowlus CL. Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry. Hepatol Commun. 2025 May 6;9(5):e0703. doi:10.1097/HC9.0000000000000703. PMID: 40366147; PMCID: PMC12055165.

Martins A, Reddy A, Dean R, Gordon SC, Pratt D, Li M, Forman L, Lammert C, Yiman K, Gallegos-Orozco J, Carey EJ, Bonder A, Schlansky BL, Montano-Loza AJ, Lytvyak E, Goldberg DS, Naugler S, Yu L, Assis D, Bowlus CL, Levy C. Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis. Liver Int. 2026 May;46(5):e70645. doi: 10.1111/liv.70645. PMID: 41964270.
 
Abstracts
David S. Goldberg, David N. Assis, Cynthia Levy, Lisa Forman, Craig Lammert, Lei Yu, Barry Schlansky, Stuart C. Gordon, Karista Peabody, Joseph Ahn, Bilal Hameed, James L. Boyer, Cynthia Tsay, Chung Heng Liu, Brad H Pollock and Christopher L. Bowlus. Characteristics of North American patients with primary sclerosing cholangitis: results from the Consortium for Autoimmune Liver Diseases (CALiD). Hepatology 2019;70(1):799A.

Bowlus CL, Assis DN, Wu JL, Levy C, Goldberg DS, Forman L, Schlansky B, Lammert C, Prenner S, Reddy KR, Gordon SC, Ahn J, Zepeda JB, Silveira MG, Boyer JL, and Pollock BH. Impact of race and ethnicity on prognostic models of outcomes in primary sclerosing cholangitis. Hepatology 2020; 72:748A-749A. 

Dean R, Yazdanfar M, Zepeda J, Levy C, Gordon S, Forman L, Lammert C, Assis DN, Pratt D, McGirr A, McLaughlin MM, Mukherjee S, Gungabissoon U, Bowlus CL. (2023). Investigating the cholestatic pruritus of primary sclerosing cholangitis (ItCh-PSC): a study of patients participating in the consortium for autoimmune liver disease (CALiD). J Hepatol 2023; 78:S388.

Dean R, Yazdanfar M, Zepeda JB, Patel I, Levy C, Lammert C, Bordia R, Cosar D, Specht K, Pratt D, Gordon S, Forman L, Barry F, Li M, Assis D, McGirr A, McLaughlin M, Mukherjee S, Gungabissoon U, Bowlus C. Investigating the cholestatic pruritus of primary sclerosing cholangitis (ItCh-PSC): a cross sectional study of patients participating in the consortium for autoimmune liver disease (CALiD). Hepatology 2024; 80:S1801-S1802.

Martins A, Reddy A, Dean, R, Patel I, Gordon S, Pratt D, Li M, Forman L, Lammert C, Yimam K, Gallegos-Orozco J, Carey E, Bonder A, Schlansky B, Montano-Loza A, Lytvyak E, Goldberg D, Naugler, W, Yu L, Levy C. Gaps in guideline adherence for primary sclerosing cholangitis in the US: a 5-year analysis of CALiD database. Gastroenterology 2025;169. S-1058.

​Levy, Cynthia, Pratt, Daniel, Lammert, Craig, Gordon, Stuart, Li, Michael, Forman, Lisa, Dean, Richard, Yazdanfar, Maryam, Patel, Isha, Bordia, Raghav, Cosar, Duru, Specht, Katherine, Barry, Fawzy, McLaughlin, Megan, Mukherjee, Sumanta, Gungabissoon, Usha, Bowlus, Christopher. Serum levels of IL-31 and autotaxin are independently associated with pruritus severity in patients with primary sclerosing cholangitis. J Hepatol 2025; 82: S315.
 
Manuscripts Under Revision
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, Isha J. Patel, Cynthia Levy, Craig Lammert, Raghav Bordia, Duru Cosar, Katherine Specht, Daniel Pratt, Stuart C. Gordon, Lisa Forman, Fawzy Barry, Michael Li, Usha Gungabissoon, Megan M. McLaughlin, and Christopher L. Bowlus. Pruritus is frequent and persistent and impacts quality of life among patients with primary sclerosing cholangitis.